Redefine feasibility in medicine
Making previously unreachable therapies achievable. Real breakthroughs come from tackling the impossible.
At Anew Therapeutics, we concentrate AI power on these exact challenges, turning biological barriers into clinical assets.

Traditional targets
- Deep pockets with clear geometric constraint
- Easy to design
- Low-hanging fruit mostly gone
Undruggable targets
- Large, flat and highly hydrophobic
- Extremely difficult even for hit finding
- Potential to address high unmet medical needs
Platforms

Leverage AI to generate customized chemical space better suited for challenging targets
Pinpointing superior molecules with unrivaled affinity insights, empowered by AI-enhanced sampling and target-centric parameterization

Research
-
FeaSynth
Highlight: FeaSynth integrates an Expert Encoding Scheme with 145 annotated reaction templates to resolve critical chemical conflicts and significantly outperform… read more
-
scNext
Highlight: scNext is a generative foundation model that transforms static single-cell data into predictive temporal sequences, enabling the forecasting of… read more
-
ΔPSA
Highlight: Cost-Effective Prediction of Macrocyclic Peptide Permeability via Dynamic Conformational Analysis We introduce a computationally efficient molecular dynamics framework that… read more

